BONE BIOLOGICS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
BONE BIOLOGICS CORPORATION (BBLG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-03-02
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-12-31 was $127.42K.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-09-30 was $150.03K, a 0.02% increase year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-06-30 was $0.00.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-03-31 was $34.04K, a 184.89% increase year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $200.00K, a 35.79% decline from fiscal 2024.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $311.48K, a 92.33% increase from fiscal 2023.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $161.95K, a 49.64% decline from fiscal 2022.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $321.59K, a 55.33% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $200.00K 10-K · filed 2026-03-02 | |||
| 2024-12-31 | $127.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $277.44K derived: sum of 2 quarters · filed 2025-02-26 | $277.44K derived: sum of 3 quarters · filed 2025-02-26 | $311.48K 10-K · filed 2025-02-26 |
| 2024-09-30 | $150.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $150.03K derived: sum of 2 quarters · filed 2024-11-14 | $184.06K 10-Q · filed 2024-11-14 | $184.06K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $34.04K 10-Q · filed 2024-08-09 | $34.04K derived: sum of 3 quarters · filed 2024-08-09 | $184.04K derived: sum of 4 quarters · filed 2024-08-09 |
| 2024-03-31 | $34.04K 10-Q · filed 2024-05-14 | $34.04K derived: sum of 2 quarters · filed 2024-05-14 | $184.04K derived: sum of 3 quarters · filed 2024-05-14 | $184.04K derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $150.00K derived: sum of 2 quarters · filed 2024-02-21 | $150.00K derived: sum of 3 quarters · filed 2024-02-21 | $161.95K 10-K · filed 2024-02-21 |
| 2023-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $150.00K derived: sum of 2 quarters · filed 2023-11-14 | $161.95K 10-Q · filed 2023-11-14 | $161.95K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $11.95K 10-Q · filed 2023-08-14 | $11.95K derived: sum of 3 quarters · filed 2023-08-14 | $161.95K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $11.95K 10-Q · filed 2023-05-15 | $11.95K derived: sum of 2 quarters · filed 2023-05-15 | $161.95K derived: sum of 3 quarters · filed 2023-05-15 | $161.95K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $150.00K derived: sum of 2 quarters · filed 2023-03-30 | $150.00K derived: sum of 3 quarters · filed 2023-03-30 | $321.59K 10-K · filed 2023-03-30 |
| 2022-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $150.00K derived: sum of 2 quarters · filed 2022-11-14 | $321.59K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $171.59K 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $171.59K 10-Q · filed 2022-05-13 | |||
| 2021-12-31 | $207.03K 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $50.00K 10-K · filed 2021-04-15 | ||
| 2019-09-30 | $50.00K 10-Q · filed 2019-11-14 | |||
| 2018-12-31 | -$537.44K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$609.50K derived: sum of 2 quarters · filed 2020-03-30 | -$267.69K derived: sum of 3 quarters · filed 2020-03-30 | $100.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | -$72.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $269.75K derived: sum of 2 quarters · filed 2018-11-16 | $637.44K 10-Q · filed 2018-11-16 | |
| 2018-06-30 | $341.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $709.50K 10-Q · filed 2018-08-14 | ||
| 2018-03-31 | $367.69K 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | $2.16M 10-K · filed 2018-04-02 | |||
| 2016-12-31 | $4.14M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |